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INTRODUCTION
Several studies have investigated the pathophysiology of
obsessive-compulsive disorder (OCD) and found evidence of
associated abnormalities in the frontal-subcortical circuits (1,
2). In particular, the orbitofrontal and anterior cingulate regions
are hypothesized to play an important role in producing the
symptoms of OCD. Several functional studies have identified
hypermetabolism in the orbitofrontal cortex, the inferior fro-
ntal gyrus, and the anterior cingulate cortex, under baseline
conditions and during symptom provocation (3, 4). Normal
metabolic activity in these regions was restored with treat-
ment (5).
Structural studies have compared regions of interest (ROI)
to observe regional changes in brain volume, or used voxel-
based morphometry (VBM) to investigate structural differ-
ences in the whole brain; however, the results of these stud-
ies were inconsistent. ROI-based studies reported decreased
volumes of the orbitofrontal cortex and the caudate nucleus in
OCD patients (6, 7), whereas Scarone et al. (8) reported that
the volume of the caudate nucleus increased compared to nor-
mal controls. Other studies have found no changes in region-
al brain volume in OCD patients (9, 10). The number of VBM
studies is limited and the findings are contradictory. A recent
study reported increased gray matter (GM) in the orbitofrontal
cortex (11), whereas Pujol et al. (12) reported that the GM
volume was reduced in the medial frontal gyrus, the medial
orbitofrontal cortex, and in the left insulo-opercular region.
In addition, although several studies identified abnormalities
in regions such as the parietal cortex (4, 11, 13), few ROI-based
studies have addressed the same regions.
We used VBM to investigate structural abnormalities associ-
ated with OCD in comparison to healthy controls in a large
number of subjects. VBM methodology has permitted investi-
gators to examine regional differences in GM density across the
entire brain without an a priori definition of anatomical borders.
We hypothesized that patients with OCD would show vol-
umetric abnormalities in specific regions, including the pari-
etal, orbitofrontal, and cingulate cortices, as well as in some
subcortical areas. We also hypothesized that abnormalities in
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Voxel-Based Morphometry Study of Gray Matter Abnormalities
in Obsessive-Compulsive Disorder
To examine regional abnormalities in the brains of patients with obsessive-compul-
sive disorder (OCD), we assessed the gray matter (GM) density using voxel-based
morphometry (VBM). We compared magnetic resonance images (MRIs) acquired
from 71 OCD patients and 71 age- and gender-matched normal controls and exam-
ined the relationship between GM density and various clinical variables in OCD patients.
We also investigated whether GM density differs among the subtypes of OCD com-
pared to healthy controls. We detected significant reduction of GM in the inferior frontal
gyrus, the medial frontal gyrus, the insula, the cingulate gyrus, and the superior tem-
poral gyrus of OCD patients. A significant increase in GM density was observed in
the postcentral gyrus, the thalamus, and the putamen. Some of these regions, includ-
ing the insular and postcentral gyrus, were also associated with the severity of obses-
sive-compulsive symptoms. These findings indicate that the frontal-subcortical cir-
cuitry is dysfunctional in OCD, and suggest that the parietal cortex may play a role
in the pathophysiology of this disease.
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GM density would be correlated with clinical variables, such as
symptom severity, duration of illness, and symptom dimensions.
MATERIALS AND METHODS
Participants
Seventy-one patients with OCD were recruited from the
outpatient clinic at Seoul National University Hospital. Diag-
noses were established using the Structured Clinical Interview
for DSM-IV Axis I disorders (SCID-IV) (14). The participants
consisted of 47 males (66.20%) and 24 females (33.80%) with
a mean (±standard deviation) age of 26.60±7.49 yr. The
mean age of males was 25.66±7.90 yr and that of females
was 28.46±6.39 yr (t=-1.501, df=69, p=0.138). The mean
age of OCD onset was 18.59±6.52 yr (males, 18.19±6.81
yr; females, 19.38±5.98 yr; t=-0.721, df=69, p=0.473). The
mean duration of the illness was 8.02±6.10 yr (males, 7.55
±6.32 yr; females, 8.95±5.67 yr; t=-0.972, df=69, p=0.365).
Sixty-eight subjects were right-handed and three subjects
were left-handed.
The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and
the symptom checklist (15) were used to assess the severity
and subtypes of OCD symptoms. Sixty-four of the patients
had completed the symptom checklist and were assigned a
score of 0 (absent), 1 (mild), or 2 (prominent) for each of the
five clinical dimensions (16). The highest score for any of the
checklist elements composing a given dimension was used as
the overall score for that dimension; a score of 2 (prominent)
was allowed for more than one dimension. The demographic
and clinical characteristics of the participants are presented in
Table 1. Four patients had a history of major depressive dis-
order (MDD) and three patients displayed anxiety disorder
with comorbidity. One patient had a history of both MDD
and anxiety disorder. Fifty-nine patients were taking selective
serotonin reuptake inhibitors (SSRIs), and the remaining sub-
jects were medication-free for at least 4 weeks prior to the study.
An equivalent number of healthy control subjects were re-
cruited from the community and assessed using the SCID-IV
to exclude any concurrent or lifetime history of DSM-IV Axis
I disorders. The control group was age- and gender-matched
to the OCD group (47 males, 24 females; mean age=26.68
±6.09 yr) and all control subjects were right-handed. None
of the control subjects had a history of Axis I psychiatric dis-
orders, neurological illnesses, or medical illnesses.
The study protocol and forms were approved by the insti-
tutional review board of Seoul National University Hospital,
and written informed consent was obtained from each subject.
Magnetic resonance image (MRI) acquisition and
processing
MRIs were obtained using a 1.5-T GE SIGNA scanner (GE
Medical Systems, Milwaukee, WI, U.S.A.). Contiguous 1.5-
mm sagittal images were obtained with a three-dimensional
MRI, magnetic resonance imaging; SD, standard deviation. *OCD symptoms were scored using Yale-Brown Obsessive Compulsive Scale checklists in
64 patients with OCD. The score of 2 (prominent) was allowed for more than 1 dimension.
Value
Demographic data of subjects by group OCD Control p
Number of subjects 71 71
Sex (male/female) 47/24 47/24
Age (yr), mean (SD) 26.61 (7.50) 26.68 (6.09) 0.42
Clinical data of OCD subjects
Duration of illness (yr), mean (SD) 8.02 (6.10)
Age of onset (yr), mean (SD) 18.59 (6.52)
Yale-Brown Obsessive Compulsive Scale, mean (SD)
Obsession score 12.35 (4.31)
Compulsion score 10.49 (5.00)
Total score 22.84 (8.40)
Score of OC symptoms, No. (%)* 0 (Absent) 1 (Mild) 2 (Prominent)
Symmetry and ordering 31 (48.44) 26 (40.63) 7 (10.94)
Hoarding 43 (67.19) 16 (25.00) 5 (7.81)
Contamination and cleaning 15 (23.44) 23 (35.94) 26 (40.63)
Aggressive and checking 5 (7.81) 30 (46.88) 29 (45.31)
Sexual/religious obsession 30 (46.86) 27 (42.19) 7 (10.94)
Treatment at time of MRI No (%) Dose (mg/day), mean (SD)
Drug-free (>4 weeks) 12 (16.90) -
Fluoxetine 19 (22.54) 42 (21.98)
Fluvoxamine 6 (8.45) 215 (69.82)
Paroxetine 7 (9.86) 50 (14.14)
Sertraline 27 (38.03) 159.38 (72.54)
Table 1. Demographic and clinical characteristics of patients with obsessive-compulsive disorder (OCD) and control subjects26 S.Y. Yoo, M.-S. Roh, J.-S. Choi, et al.
T1-weighted spoiled gradient-echo sequence (echo time=5.5
ms; repetition time=14.4 ms; flip angle=20°; field of view=
21×21 cm; matrix=256×256).
All MRIs were loaded into the image-processing software
package ANALYZE (version 4.1; Mayo Foundation, Roche-
ster, NY, U.S.A.) and spatially realigned along the antero-pos-
terior axis of the brain parallel to the intercommissural line.
Then, the images were filtered using anisotropic diffusion meth-
odsto improve the signal-to-noise ratio.
A VBM template was created specifically for this study, which
is necessary when working with a large number of subjects
(17). The realigned filtered MRIs from the OCD patients and
healthy controls were spatially normalized to the ICBM 152
template (Montreal Neurological Institute, Montreal, Canada),
then smoothed with an 8-mm full-width at half-maximum
(FWHM) isotropic Gaussian kernel. The normalized smoothed
images were averaged to provide the customized template.
All 142 MRIs were normalized to the same high-resolution
stereotactic space by registering each of the images to the cus-
tomized template. This process was accomplished by minimiz-
ing the residual sum of the difference between the images and
the study template. These spatially normalized images were
re-sliced using trilinear interpolation to a final voxel size of
2.0×2.0×2.0  L, and then segmented into GM, white mat-
ter (WM), and cerebrospinal fluid (CSF) using a modified mix-
ture model cluster analysis with correction for image inten-
sity nonuniformity. The resulting images were then smoothed
with a 12-mm Gaussian kernel to render the data more nor-
mally distributed. GM images were analyzed using VBM.
Statistical analysis
Intracranial volume and the volume of the three types of
brain tissue (GM, WM, and CSF) were compared using inde-
pendent samples t-tests. The values for GM, WM, and CSF
were obtained from non-normalized images, and the intracra-
nial volume was calculated as the sum of these three values.
The processed images for GM were compared between the
OCD and control groups using the t-test group comparison
in SPM2 (Statistical Parameter Mapping, version 2; Math-
Works, Natick, MA, U.S.A.). In addition, GM images were
compared separately according to gender. Exploratory anal-
yses compared patients with predominant contamination/
cleaning (n=26) or aggressive/checking (n=29) symptoms (the
only subgroups large enough for analysis) to the healthy con-
trol subjects.
The SPM (t) maps were then transformed into the unit nor-
mal distribution (SPM [Z]) and thresholded at a voxel level of
p<0.001 (uncorrected) with a cluster threshold of 20 voxels.
This threshold was chosen based on several previous structural
imaging studies using SPM analyses (11); it provides protec-
tion against false-positive results when clear hypotheses exist
as to the location of the abnormality.
Finally, simple regression analyses were performed to deter-
mine whether a relationship exists between whole brain GM
density and the clinical variables of OCD, including symptom
severity and duration of the illness.
RESULTS
Global volume measurements
Intracranial volumes were similar in OCD patients and con-
trol subjects (1825.28±201.98  L vs. 1818.57±201.09 L,
respectively; t140=0.198; p=0.843). No differences were found
in GM, WM, or CSF volumes between OCD patients and con-
trol subjects (GM, 740.01±65.63 m3vs. 737.75±62.69 L,
respectively; t140=0.209, p=0.834; WM, 455.89±53.54 L
vs. 452.54±49.59 L,  respectively;  t140=0.387, p=0.699; CSF,
629.38±105.52  L vs. 628.28±111.59 L,  respectively;
t140=0.060, p=0.952).
Differences in GM density
Significant decreases in GM density were detected in the
cingulate gyrus of patients with OCD, especially in the ante-
rior cingulate gyrus, the frontal lobe (bilateral inferior frontal
Fig. 1. Statistical parametric mapping displaying gray matter (GM) density differences between patients with obsessive-compulsive disorder
(OCD) and healthy controls. Significant changes of GM density with cluster of more than 20 voxels at  <0.001, uncorrected for multiple com-
parisons are displayed. Note that significant decreases of GM density are identified in the right cingulate gyrus, bilateral frontal lobe, bilateral
insular, and left superior temporal gyrus (A), whereas GM densities of the bilateral postcentral gyrus, right thalamus, and left putamen are
significantly increased in patients with OCD (B). The color scale shows t values for each significant voxel.
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gyrus, right medial frontal gyrus, right precentral gyrus, and
left middle frontal gyrus), the bilateral insular gyrus, and the
left superior temporal gyrus (Fig. 1 and Table 2). In contrast,
the bilateral postcentral gyrus, the right thalamus, and the
left putamen showed significant increases in GM density in
OCD patients (Fig. 1 and Table 2). These results remained
statistically significant when we excluded patients with
comorbid diagnoses from the analysis. Exploratory analyses
indicated that patients with contamination/cleaning symp-
toms showed significantly less GM volume in the anterior
cingulate gyrus, the middle frontal gyrus, and the cingulate
gyrus. However, they showed increased GM volume in the
medial frontal gyrus and postcentral gyrus compared to
healthy controls. Patients with aggressive/checking symp-
toms showed less GM volume in the superior temporal
gyrus, middle frontal gyrus, anterior cingulate gyrus, and
insular gyrus, and increased GM volume in the right post-
central gyrus (Table 3).
Gender-specific analyses of GM density
Female patients displayed decreased GM density in the right
middle frontal gyrus (757 voxels, Z-max=4.38, coordinates
x,y,z=54, 44, -10), the right superior frontal gyrus (73 voxels,
Z-max=4.07, coordinatesx,y,z=16, 20, 48), the left precentral
gyrus (153 voxels, Z-max=4.01, coordinatesx,y,z=-50, 10, 4),
and the left cingulate gyrus (43 voxels, Z-max=3.62, coor-
dinatesx,y,z=-20, 20, 26) compared to healthy female controls.
Female OCD subjects displayed no regional differences in
GM density compared to the healthy female controls. Male
OCD subjects showed decreased GM density in the medial
frontal gyrus bilaterally (891 voxels, Z-max=4.24, coordi-
natesx,y,z=-6, 40, 24), the right inferior frontal gyrus (87 vox-
els, Z-max=3.89, coordinatesx,y,z=34, 24, -6), the bilateral ante-
rior cingulate gyrus (310 voxels, Z-max=3.71, coordinatesx,y,z=
2, 18, -2), and the bilateral insular gyrus (70 voxels, Z-max=
3.73, coordinatesx,y,z=-40, 18, 4; 88 voxels, Z-max=3.57, coor-
dinatesx,y,z=42, 8, -2). Male OCD patients showed increased
GM density in the right postcentral gyrus (85 voxels, Z-max
=3.94, coordinatesx,y,z=16, -56, 70), the left superior parietal
lobule gyrus (65 voxels, Z-max=3.70, coordinatesx,y,z=-20,
Coordinates (x, y, z) refer to the brain atlas of Talairach and Tournoux (40).
Only clusters showing a spatial extent of at least 20 contiguous voxels are
reported.
Regions
Z No.
sco- of
res voxels
Talairach
coordinates
xyz
Increase 
Right postcentral gyrus 18 -49 70 4.38 326
Right thalamus 26 -27 1 3.69 62
Left postcentral gyrus -18 -41 67 3.55 77
Left putamen -28 2 -2 3.38 67
Decrease
Right cingulate gyrus 6 26 23 4.29 1,515
Right inferior frontal gyrus 34 23 -6 4.20 196
Left inferior frontal gyrus -34 23 -8 4.18 133
Right medial frontal gyrus 6 34 -12 3.96 515
Left insula -44 14 3 3.85 169
Left superior temporal gyrus -38 16 -26 3.66 36
Right supramarginal gyrus 57 -37 31 3.61 26
Right precentral gyrus 59 8 12 3.53 53
Right insula 42 10 1 3.41 55
Left middle frontal gyrus -36 58 -8 3.28 38
Table 2. Regional gray matter density changes in patients with
obsessive-compulsive disorder 
*Prominent symptom dimensions were defined by Mataix-Cols et al. (16) The comparisons were done between patients with and without each promi-
nent symptom. 
� Coordinates (x, y, z) refer to the brain atlas of Talairach and Tournoux (40). Only clusters showing a spatial extent of at least 20 con-
tiguous voxels are reported. OCD, obsessive-compulsive disorder.
Prominent symptom dimensions*
Talairach coordinates
�
Z score No. of voxels 
xyz
Contamination and cleaning
Increase Left medial frontal gyrus -4 -10 64 4.10 292
Right postcentral gyrus 14 -54 68 3.76 209
Left postcentral gyrus -20 -44 72 3.57 51
Decrease Right anterior cingulate gyrus 4 32 -11 3.64 175
Left middle frontal gyrus -28 38 22 3.55 30
Right cingulate gyrus -2 10 30 3.36 35
Aggressive and checking
Increase Right postcentral gyrus 18 -52 72 3.84 74
Decrease Right superior temporal gyrus 46 18 -26 5.36 887
Left superior frontal gyrus -28 62 -6 4.80 2,359
Right middle frontal gyrus 42 52 -12 4.40 1,475
Anterior cingulate gyrus 8 46 -6 4.25 1,783
Right insula 36 10 6 3.96 365
Left superior temporal gyrus -50 -28 12 3.64 182
Left inferior parietal gyrus -48 -36 38 3.44 27
Table 3. Differences in regional gray matter density between healthy controls and OCD patients with the prominent symptom dimensions 28 S.Y. Yoo, M.-S. Roh, J.-S. Choi, et al.
-66, 58), and the left lentiform nucleus (49 voxels, Z-max=
3.44, coordinatesx,y,z=-28, -12, -4), compared to healthy male
controls.
Correlation of GM density with clinical variables
We investigated whether GM density is correlated with
clinical variables in OCD patients. Obsession and compul-
sion diagnostic scores were analyzed separately. Obsession
scores were positively correlated with voxels in the right insu-
la (47 voxels, Z-max=4.90, coordinatesx,y,z=44, -11, 21) and
the precuneus (58 voxels, Z-max=3.94, coordinatesx,y,z=0, -66,
46), but negatively correlated with voxels in the right post-
central gyrus (53 voxels, Z-max=4.19, coordinatesx,y,z=63, -18,
38) and the right transverse temporal gyrus (40 voxels, Z-
max=4.00, coordinatesx,y,z=63, -7, 11). We found clusters of
significant positive correlation with compulsion scores in the
precuneus (286 voxels, Z-max=5.30, coordinatesx,y,z=0, -64,
46), the right cingulate gyrus (45 voxels, Z-max=4.65, coor-
dinatesx,y,z=14, 29, 28), and the left medial frontal gyrus (26
voxels, Z-max=3.25, coordinatesx,y,z=-6, -13, 52). Moreover,
three clusters of negative correlation with compulsion scores
were found in the left superior temporal gyrus (-63 voxels, Z-
max=3.97, coordinatesx,y,z=-63, -19, -2), the superior frontal
gyrus (23 voxels, Z-max=3.71, coordinatesx,y,z=-16, 18, 51),
and the left anterior cingulate gyrus (38 voxels, Z-max=3.46,
coordinatesx,y,z=-2, 39, -1).
The duration of illness and GM density were negatively
correlated in several brain regions, primarily in the left hemi-
sphere, including the left postcentral gyrus (217 voxels, Z-
max=4.55, coordinatesx,y,z=-44, -28, 44), the left supramarginal
gyrus (103 voxels, Z-max=4.25, coordinatesx,y,z=-62, -48, 24),
the left precentral gyrus (314 voxels, Z-max=4.15, coordi-
natesx,y,z=-50, -6, 42), the left middle and superior temporal
gyrus (113 voxels, Z-max=4.10, coordinatesx,y,z=-50, 4, -34;
45 voxels, Z-max=3.45, coordinatesx,y,z=-66, -24, 2), the left
inferior frontal gyrus (34 voxels, Z-max=3.62, coordinatesx,y,z=
-48, 24, -10), and the right inferior parietal lobule (68 vox-
els, Z-max=3.78, coordinatesx,y,z=60, -40, 48). No cases of
significant positive correlation were observed between the
duration of the illness and GM density.
DISCUSSION
We investigated abnormalities in GM density in OCD pa-
tients compared to healthy control subjects. OCD patients
displayed decreased GM density in the cingulate gyrus, espe-
cially in the anterior cingulate gyrus, the frontal gyrus, the
insular gyrus, and the temporal gyrus. In contrast, we noted
significantly increased GM density in the postcentral gyrus,
the right thalamus, and the left putamen.
The regions of the brain that showed significant differences
in GM density compose the frontal-subcortical circuits, which
may be involved in the pathophysiology of OCD. The anteri-
or cingulate gyrus is hypothesized to produce the symptoms
associated with OCD (18). Neuropsychological impairments
revealed by the controlled oral word association test in OCD
patients may be related to the of the frontaomedial-anterior
cingulate dysfunction (19).
The inferior frontal gyrus, particularly the ventral area, and
the medial frontal gyrus were designated as part of the orbito-
frontal cortex in previous studies (1, 18). Volume reduction
in the orbitofrontal cortex has been reported more frequently
than that of other regions of the frontal-subcortical circuits
(20). The orbitofrontal cortex is thought to play an important
role in the pathophysiology of OCD through the recognition
of biologically significant stimuli and the mediation of auto-
nomic and goal-directed responses (21). In addition, Savage
et al. (22) reported that verbal and nonverbal episodic mem-
ories are deficient in OCD patients, and that the orbitofrontal
cortex plays a role in mobilizing strategies during novel or
ambiguous verbal learning tasks, and in directing the strate-
gic memory process. A decreased GM density in the frontal
cortex may be related to the symptoms and neuropsycholog-
ical impairments observed in OCD patients. The hyperactiv-
ity of the orbitofrontal cortex observed in functional imaging
studies may be attributable to residual tissues compensating
for decreased GM volumes. 
We found increased GM density in the parietal cortex, the
thalamus, and the putamen in patients with OCD, which may
reflect increased neuronal size, hypertrophy, or other patho-
physiological processes. Rosenberg et al. (23) suggested that
increased cortical volumes in OCD may result from delayed
or inefficient pruning of neurons during development. Another
possible explanation is that cortical volume increases to com-
pensate for dysfunctional frontal-striatal regions. The patients
in our study were relatively young and ill for only a short peri-
od of time. These characteristics lead us to speculate that their
brains may have some ability to compensate for dysfunctional
regions, such as the frontal-striatal regions. This idea is sup-
ported by our finding that GM density in the parietal cortex
is negatively correlated with symptom severity.
Structural and functional imaging studies have implicated
the parietal cortex in the pathology of OCD. Valente et al. (11)
reported the reduction of GM in the right parietal associative
cortex, and Kwon et al. (13) observed hypometabolism in the
left inferior parietal cortex in OCD patients. However, little
attention has been paid to parietal cortex dysfunction and the
pathophysiology of OCD. The parietal cortex is associated with
several functions relevant to the clinical expression of OCD,
including the dynamic aspects of executive functioning, set
shifting, goal setting in planned behavior, inhibition, and
visuospatial processing, suggesting that parietal dysfunction
may underlie the cognitive deficits observed in patients with
OCD (24, 25). Moreover, dysfunction of the parietal cortex
may interact with some of the key regions implicated in OCD
via direct anatomical connections; these regions may includeVoxel-Based Morphometry in Obsessive-Compulsive Disorder 29
the lateral OFC (21), the striatum (26), and the mediodorsal
thalamic nucleus (27). These findings suggest that the pari-
etal cortex, as well as the frontal-subcortical circuits, play a
role in expressing the clinical symptoms of OCD. 
We observed gender-dependent differences in GM density
between OCD patients and healthy controls. Previous studies
have shown gender-related differences in patients with MDD
(28), schizophrenia (29), and bipolar disorder (30). These dif-
ferences may be the result of various factors, including nor-
mal sexual dimorphism (31) and hormone effects (32). Fur-
ther studies are required to determine the relationship between
the gender-specific characteristics of OCD and brain mor-
phometry.
We also found that symptom dimensions were associated
with different regions, which was previously noted in several
functional imaging studies (16, 33). One study used a wash-
ing experiment to demonstrate that patients exhibited differ-
ences in blood flow, primarily in the ventromedial prefrontal
regions. In contrast, differences in blood flow were found pri-
marily in the subthalamic and dorsal cortical regions in check-
ing experiments (32). These results suggest that different OCD
symptom dimensions are mediated by relatively distinct, but
partially overlapping, neural components of the fronto-stri-
ato-thalamic circuits.
We found that symptom scores were positively correlated
with decreased GM density in the cingulate gyrus and the
medial frontal gyrus. These results appear to be in conflict with
each other. However, decreased GM density may be associated
with the pathophysiology of OCD but not the symptoms;
instead, symptoms may be produced by the remaining func-
tional regions. In our study, lower GM density was associat-
ed with an extended duration of illness.
This study had several limitations. First, the majority of
OCD patients in this study were taking medication. Several
studies have suggested that medication affects regional brain
volumes (34, 35). We cannot exclude the possibility that at
least some of the changes in GM density observed in OCD
patients might have been related to the medication. Second,
our findings did not perfectly replicate the results of previous
ROI studies (7, 10). Several previous studies have reported
differences between the results of VBM studies and those of
manual ROI analyses (36, 37). False-positive or false-negative
VBM results may arise from changes in the shape or displace-
ment of structures during spatial normalization (37); in addi-
tion, ROI analyses may inadvertently include portions of the
surrounding white matter (36). Finally, the discrepancies among
various structural studies may be attributable to the nature of
OCD itself. Several studies have shown that OCD is a mul-
tidimensional and etiologically heterogeneous condition. The
symptom dimensions of OCD, such as doubt/checking, con-
tamination/ washing, and symmetry/ordering, may be useful
in genetic, neurobiological, and treatment response studies
(38, 39).
In summary, our study found abnormalities in the parietal
cortex as well as the frontal-subcortical circuits of patients with
OCD, and distinct GM abnormalities associated with the sym-
ptom dimensions of OCD. Further studies are required to elu-
cidate the role of the parietal cortex in OCD.
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